Role of SUMO Conjugation in Ischemia: Significance, Mechanisms and Pathways

SUMO 结合在缺血中的作用：意义、机制和途径

• 批准号: 9049555
• 负责人: WULF PASCHEN
• 金额: $ 34.34万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-15 至 2017-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9049555
• 关键词: Affect; Arthritis; Brain; Cell Culture Techniques; Cells; Cellular Stress; Cerebral Ischemia; Cessation of life; Critical Pathways; DNA Repair; Data; Degenerative Disorder; Development; Diabetes Mellitus; Disease; Fostering; Gene Expression; Genome Stability; Genomics; Goals; Health; Heart failure; Histology; Individual; Interruption; Ischemia; Knockout Mice; Knowledge; Laboratories; Learning; Life; Link; Malignant Neoplasms; Memory; Mission; Neurons; Organ; Outcome; Pathway interactions; Play; Preventive; Preventive Intervention; Process; Proteins; Proteomics; Public Health; Quality Control; Reaction; Recovery; Recovery of Function; Research; Resistance; Role; Stress; Sumoylation Pathway; Testing; Therapeutic; Therapeutic Intervention; Transgenic Animals; Transgenic Mice; Transgenic Organisms; Transient Cerebral Ischemia; Translating; Ubiquitin; Ubiquitination; Vascular blood supply; Western Blotting; Work; analytical tool; base; behavior test; biological adaptation to stress; cell injury; clinically relevant; clinically significant; design; improved; in vivo; innovation; knockout animal; mouse model; novel; protein degradation; restoration

DESCRIPTION (provided by applicant): Small ubiquitin-like modifier (SUMO) conjugation modulates all major cellular pathways, including those associated with gene expression and genome stability, protein quality control, proteasomal degradation of proteins and DNA damage repair. Transient cerebral ischemia massively activates SUMO conjugation, resulting in a dramatic rise in levels of SUMO2/3-conjugated proteins. Cell culture studies suggest that the post- ischemic activation of SUMO2/3 conjugation is a protective stress response. However, the role of SUMO conjugation in the fate of post-ischemic neurons in the intact brain and the mechanisms and pathways that link SUMO conjugation to restoration of function impaired by transient ischemia are not known. Without this knowledge it is highly unlikely that the SUMO conjugation pathway can be manipulated for therapeutic purposes. Our long-term goal is to understand how to manipulate the SUMO conjugation pathway for preventive and therapeutic purposes. The objective of this particular application is to elucidate the role of individual SUMO paralogues in the recovery of neurons from ischemic stress and to identify the mechanisms and pathways involved. The central hypothesis is that SUMO conjugation plays a key role in modulating path- ways that are critical for death/survival decisions in post-ischemic neurons. This hypothesis has been formulated on the basis of data produced in our laboratory. The rationale for the proposed studies is that after we have verified the protective role of SUMO conjugation in post-ischemic neurons in vivo and have identified the underlying mechanisms and pathways, we will have established an important platform for designing new strategies for preventive and therapeutic interventions in clinically relevant pathological states associated with a transient episode of insufficient blood supply. Based on strong preliminary data and the development of novel SUMO transgenic and knockout animals in our laboratory, the hypothesis will be tested by pursuing the following specific aims: 1) Characterize new SUMO transgenic and knockout mouse models; 2) Determine the effects of individual SUMO paralogues on post-ischemic neuronal cell damage and functional recovery; 3) Determine how SUMO conjugation is linked to the fate of post-ischemic neurons; 4) Determine how transient ischemia affects the crosstalk between ubiquitin and SUMO conjugation. The approach is innovative because it is the first study to use SUMO transgenic and knockout animals and to per- form proteomic analyses to determine the role of SUMO conjugation in cerebral ischemia. The proposed research is significant, because we expect to uncover the mechanisms that link SUMO conjugation to the viability and function of post-ischemic neurons. Ultimately, such knowledge is expected to translate into new strategies for therapeutic intervention in pathological states associated with an episode of insufficient blood supply and in other disorders associated with the SUMO conjugation pathway, including diabetes, heart failure, and degenerative diseases.

描述（由申请人提供）：小泛素样修饰剂 (SUMO) 缀合可调节所有主要细胞途径，包括与基因表达和基因组稳定性、蛋白质质量控​​制、蛋白质蛋白酶体降解和 DNA 损伤修复相关的途径。短暂性脑缺血会大量激活 SUMO 结合，导致 SUMO2/3 结合蛋白水平急剧上升。细胞培养研究表明，SUMO2/3 结合的缺血后激活是一种保护性应激反应。然而，SUMO 结合在完整大脑缺血后神经元命运中的作用以及将 SUMO 结合与短暂性缺血受损功能恢复联系起来的机制和途径尚不清楚。如果没有这些知识，就不可能操纵 SUMO 缀合途径用于治疗目的。我们的长期目标是了解如何操纵 SUMO 缀合途径以达到预防和治疗目的。这一特定应用的目的是阐明各个 SUMO 旁系同源物在神经元从缺血应激中恢复中的作用，并确定所涉及的机制和途径。中心假设是 SUMO 结合在调节对缺血后神经元死亡/生存决定至关重要的途径中发挥着关键作用。这一假设是根据我们实验室产生的数据制定的。拟议研究的基本原理是，在我们体内验证了 SUMO 结合对缺血后神经元的保护作用并确定了潜在的机制和途径后，我们将建立一个重要的平台，用于设计与缺血相关的临床相关病理状态的预防和治疗干预新策略。 短暂的血液供应不足。基于强有力的初步数据以及我们实验室新型 SUMO 转基因和敲除动物的开发，将通过追求以下具体目标来检验该假设： 1）表征新的 SUMO 转基因和敲除小鼠模型； 2) 确定各个SUMO旁系同源物对缺血后神经元细胞损伤和功能恢复的影响； 3）确定SUMO缀合如何与缺血后神经元的命运相关； 4) 确定短暂性缺血如何影响泛素和 SUMO 结合之间的串扰。该方法具有创新性，因为它是第一项使用 SUMO 转基因和基因敲除动物并进行蛋白质组学分析以确定 SUMO 结合在脑缺血中的作用的研究。这项研究意义重大，因为我们希望揭示 SUMO 结合与缺血后神经元活力和功能之间的联系机制。最终，这些知识有望转化为治疗干预的新策略，用于治疗与血液供应不足相关的病理状态以及与 SUMO 结合途径相关的其他疾病，包括糖尿病、心力衰竭和退行性疾病。